Adele C. Viguera, MD

  • 13Articles
  • 125.7KReads
  • 2001–2024Active
  • 54Collaborators
  • 89Citations

About

Adele C. Viguera, MD, is affiliated with the Ammon-Pinizzotto Center for Women’s Mental Health at Massachusetts General Hospital and the Cleveland Clinic Neurological Institute. Her publications, spanning from 2001 to 2024, focus on psychiatric conditions in women, including bipolar disorder, major depressive disorder, premenstrual dysphoric disorder, and psychotic disorders. She has contributed extensively to research on the reproductive safety of second-generation antipsychotics, prenatal exposure effects, and treatment approaches for mood disorders related to reproductive stages.

Publications

JCP
Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior in Preschool-Aged Children
Original Research

Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior in Preschool-Aged Children

March 13, 2024

Outcomes of children exposed in utero to second-generation antipsychotics (SGAs) were compared to those of children unexposed to SGAs in a cohort of mothers with a history of psychiatric...
, , , et al
JCP
Risk of PNAS in SGA-Exposed Infants
Original Research

Risk of PNAS in SGA-Exposed Infants

January 4, 2023

Roughly 30% of infants exposed to SGAs in utero exhibited poor neonatal adaptation syndrome; the percentage among antidepressant-exposed infants was similar.
, , , et al
JCP
Accumulation of Reproductive Safety Data for SGAs
Commentary

Accumulation of Reproductive Safety Data for SGAs

June 8, 2022

This commentary on an article by Yakuwa and colleagues calls for an acceleration of the acquisition of clinical data on the safety of second-generation antipsychotics for pregnant women and...
JCP
Correction

Correction. Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics

October 5, 2021

, , , et al
JCP
Reproductive Safety of Second-Generation Antipsychotics
Original Research

Reproductive Safety of Second-Generation Antipsychotics

August 3, 2021

What do data from a pregnancy registry demonstrate about the risk of major malformations among infants exposed to second-generation antipsychotics during the first trimester?
, , , et al
JCP
Perspectives on the New FDA Pregnancy and Lactation Labeling Rule
Academic Highlights

Perspectives on the New FDA Pregnancy and Lactation Labeling Rule

July 17, 2018

Pregnancy labeling of prescription medications in the US is in the midst of a major transformation. Are you aware of the changes? Read this summary of a recent conference...
, , , et al
JCP
Article

Establishment of the National Pregnancy Registry for Atypical Antipsychotics

April 22, 2015

, , , et al
JCP
Article

Comparison of Women With Confirmed Versus Presumably Misdiagnosed Bipolar Disorder

December 27, 2011

, , , et al
JCP
Academic Highlights

International Consensus Group on the Evidence-Based Pharmacologic Treatment of Bipolar I and II Depression

October 31, 2008

, , , et al
JCP
Article

Treatment of Premenstrual Worsening of Depression With Adjunctive Oral Contraceptive Pills: A Preliminary Report

December 14, 2007

, , , et al
JCP
Article

Birth Outcomes Following Prenatal Exposure to Antidepressants

August 15, 2007

, , , et al
JCP
Article

Treatment of Depression and Menopause-Related Symptoms With the Serotonin-Norepinephrine Reuptake Inhibitor Duloxetine

June 15, 2007

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe